First vaccine to target dendritic cells, key activators of the immune system Novel delivery of the HIV envelope protein potentially critical to future vaccine strategies Safe and able
CD40HVac, a therapeutic vaccine candidate in immuno-oncology targeting dendritic cells LinKinVax, a clinical-stage biotechnology company specialized in innovative protein-based vaccines, and Gustave
LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Alexandra Powell-Smith, PhD, Head of regulatory affairs Hasnae Niang, Head of Quality Thierry Menguy, PhD, Head of CMC activities Valérie Bouchara, PhD, Head of clinical operations